Company Kali Inc OTC Bulletin Board

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2020	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
2020	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI

Kali, Inc. is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.

USD in Million	2017	Weight	2018	Weight	Delta
Pharmaceuticals 100.0 %	0	100.0 %	0	100.0 %	-3.44%

USD in Million	2017	Weight	2018	Weight	Delta
China 100.0 %	0	100.0 %	0	100.0 %	-3.44%

Managers	Title	Age	Since
Frederick Ferri CEO	Chief Executive Officer	-	19/18/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	285,133,954	282,282,614 ( 99.00 %)	0	98.86 %
Stock B	0	394,478	0	0

Kali, Inc.

8300 Douglas Avenue Suite 800

75225, Dallas

http://www.kali-extracts.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals